Li Kang Biomedical Co Ltd (6242) — Net Asset Quality Index
Li Kang Biomedical Co Ltd (6242) has a Net Asset Quality Index of 80.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$1.09 Billion minus total liabilities of NT$212.01 Million yields net assets of NT$881.47 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Li Kang Biomedical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Li Kang Biomedical Co Ltd Net Asset Quality Index Over Time (2002–2025)
This chart shows how Li Kang Biomedical Co Ltd's Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of March 2026, the index stands at 80.6%, representing net assets of NT$881.47 Million against total assets of NT$1.09 Billion TWD. For live market cap and overall valuation, see Li Kang Biomedical Co Ltd market capitalisation.
Annual Net Asset Quality Index for Li Kang Biomedical Co Ltd (2002–2025)
The table below presents the year-by-year Net Asset Quality Index for Li Kang Biomedical Co Ltd from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 6242 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 79.7% | NT$871.24 Million | NT$1.09 Billion | NT$221.82 Million | ▼ -2.9 pp |
| 2024 | 82.6% | NT$855.68 Million | NT$1.04 Billion | NT$179.93 Million | ▲ +6.4 pp |
| 2023 | 76.2% | NT$630.03 Million | NT$827.00 Million | NT$196.97 Million | ▼ -6.6 pp |
| 2022 | 82.8% | NT$570.14 Million | NT$688.84 Million | NT$118.70 Million | ▲ +2.9 pp |
| 2021 | 79.9% | NT$492.00 Million | NT$616.07 Million | NT$124.07 Million | ▲ +1.0 pp |
| 2020 | 78.8% | NT$508.30 Million | NT$644.77 Million | NT$136.46 Million | ▲ +1.7 pp |
| 2019 | 77.2% | NT$483.44 Million | NT$626.44 Million | NT$143.00 Million | ▲ +0.6 pp |
| 2018 | 76.6% | NT$466.92 Million | NT$609.85 Million | NT$142.93 Million | ▲ +1.8 pp |
| 2017 | 74.8% | NT$445.68 Million | NT$596.06 Million | NT$150.38 Million | ▲ +13.3 pp |
| 2016 | 61.4% | NT$340.80 Million | NT$554.77 Million | NT$213.96 Million | ▲ +8.2 pp |
| 2015 | 53.2% | NT$280.29 Million | NT$526.73 Million | NT$246.44 Million | ▼ -16.9 pp |
| 2014 | 70.1% | NT$227.44 Million | NT$324.37 Million | NT$96.93 Million | ▲ +48.4 pp |
| 2013 | 21.7% | NT$24.29 Million | NT$111.79 Million | NT$87.50 Million | ▼ -36.0 pp |
| 2012 | 57.7% | NT$85.12 Million | NT$147.57 Million | NT$62.45 Million | ▼ -9.8 pp |
| 2011 | 67.5% | NT$123.43 Million | NT$182.81 Million | NT$59.37 Million | ▼ -0.2 pp |
| 2010 | 67.8% | NT$104.31 Million | NT$153.96 Million | NT$49.65 Million | ▲ +16.9 pp |
| 2009 | 50.8% | NT$128.49 Million | NT$252.83 Million | NT$124.35 Million | ▲ +7.2 pp |
| 2008 | 43.6% | NT$191.32 Million | NT$438.89 Million | NT$247.58 Million | ▼ -15.0 pp |
| 2007 | 58.6% | NT$411.54 Million | NT$701.86 Million | NT$290.32 Million | ▲ +30.1 pp |
| 2006 | 28.5% | NT$215.94 Million | NT$757.63 Million | NT$541.69 Million | ▲ +0.3 pp |
| 2005 | 28.2% | NT$223.45 Million | NT$791.11 Million | NT$567.66 Million | ▼ -14.0 pp |
| 2004 | 42.2% | NT$323.44 Million | NT$766.35 Million | NT$442.91 Million | ▼ -1.7 pp |
| 2003 | 43.9% | NT$338.06 Million | NT$770.15 Million | NT$432.09 Million | ▼ -1.5 pp |
| 2002 | 45.4% | NT$347.64 Million | NT$765.96 Million | NT$418.31 Million | — |